|Evaluation of the immortalised mouse brain capillary endothelial cell line, b. End3, as an in vitro blood-brain barrier model for drug uptake and transport studies|
Y Omidi, L Campbell, J Barar, D Connell, S Akhtar, M Gumbleton
Brain Research 990 (1-2), 95-112, 2003
|Kinetic analysis of drug release from nanoparticles|
M Barzegar-Jalali, K Adibkia, H Valizadeh, ...
Journal of Pharmacy & Pharmaceutical Sciences 11 (1), 167-177, 2008
|Ocular novel drug delivery: impacts of membranes and barriers|
J Barar, AR Javadzadeh, Y Omidi
Expert Opinion on Drug Delivery 5 (5), 567-581, 2008
|Cytotoxic impacts of linear and branched polyethylenimine nanostructures in A431 cells|
V Kafil, Y Omidi
BioImpacts 1 (1), 23-30, 2011
|Anatomy and physiology of the human eye: effects of mucopolysaccharidoses disease on structure and function–a review|
CE Willoughby, D Ponzin, S Ferrari, A Lobo, K Landau, Y Omidi
Clinical & Experimental Ophthalmology 38, 2-11, 2010
|Improved Taxol production by combination of inducing factors in suspension cell culture of Taxus baccata|
AY Khosroushahi, M Valizadeh, A Ghasempour, M Khosrowshahli, ...
Cell Biology International 30 (3), 262-269, 2006
|Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin-and oligofectamine-induced gene expression changes in human epithelial cells|
Y Omidi, AJ Hollins, M Benboubetra, R Drayton, IF Benter, S Akhtar
Journal of Drug Targeting 11 (6), 311-323, 2003
|Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis|
K Adibkia, MRS Shadbad, A Nokhodchi, A Javadzedeh, M Barzegar-Jalali, ...
Journal of Drug Targeting 15 (6), 407-416, 2007
|Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy|
J Barar, Y Omidi
BioImpacts: BI 3 (4), 149-162, 2013
|Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type|
Y Omidi, AJ Hollins, RM Drayton, S Akhtar
Journal of Drug Targeting 13 (7), 431-443, 2005
|Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity|
AJ Hollins, Y Omidi, IF Benter, S Akhtar
Journal of Drug Targeting 15 (1), 83-88, 2007
|Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer|
M Azhdarzadeh, F Atyabi, AA Saei, BS Varnamkhasti, Y Omidi, M Fateh, ...
Colloids and Surfaces B: Biointerfaces 143, 224-232, 2016
|Optical and electrochemical DNA nanobiosensors|
JEN Dolatabadi, O Mashinchian, B Ayoubi, AA Jamali, A Mobed, D Losic, ...
TrAC Trends in Analytical Chemistry 30 (3), 459-472, 2011
|Ocular drug delivery: impact of in vitro cell culture models|
J Barar, M Asadi, SA Mortazavi-Tabatabaei, Y Omidi
Journal of Ophthalmic & Vision Research 4 (4), 238-252, 2009
|An ultra-sensitive impedimetric immunosensor for detection of serum antigen CA-125 in ovarian cancer patients|
M Johari-Ahar, MR Rashidi, J Barar, M Agaie, D Mohammadnejad, ...
Nanoscale 7, 3768-3779, 2015
|Modification of polythiophene by the incorporation of processable polymeric chains: Recent progress in synthesis and applications|
M Jaymand, M Hatamzadeh, Y Omidi
Progress in Polymer Science 47, 26-69, 2015
|Evaluation of generation 2 and 3 poly (propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor|
AJ Hollins, M Benboubetra, Y Omidi, BH Zinselmeyer, AG Schatzlein, ...
Pharmaceutical Research 21 (3), 458-466, 2004
|Blood-brain barrier transport machineries and targeted therapy of brain diseases|
J Barar, M Rafi, M Pourseif, Y Omidi
Bioimpacts 6 (4), 225-248, 2016
|Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits|
K Adibkia, Y Omidi, MR Siahi, AR Javadzadeh, M Barzegar-Jalali, J Barar, ...
Journal of Ocular Pharmacology and Therapeutics 23 (5), 421-432, 2007
|Toxicogenomics of cationic lipid-based vectors for gene therapy: impact of microarray technology|
Y Omidi, J Barar, S Akhtar
Current drug delivery 2 (4), 429-441, 2005